申请人:Bock G. Mark
公开号:US20050261327A1
公开(公告)日:2005-11-24
Compounds disclosed herein are bradykinin B1 antagonist compounds useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
本文披露的化合物是布雷金肽B1拮抗剂化合物,可用于治疗或预防与布雷金肽B1途径相关的疼痛和炎症症状。